Article
Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome
2025-12-16
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Fragile X syndrome (FXS) is characterized by sensory hypersensitivity and neural hyperexcitability linked to GABAergic dysfunction. BAER-101, formerly known as AZD7325, is a positive allosteric modulator of GABA <sub>A</sub> receptors with functional selectivity for α2/α3 subunits, designed to enhance inhibitory tone while minimizing sedation associated wit...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c166421d-2188-537e-9353-28be2c088d32
- DOI
- 10.21203/rs.3.rs-8123031/v1
